| Literature DB >> 27386435 |
Seyed Mohsen Aghajanpour-Mir1, Ebrahim Zabihi2, Haleh Akhavan-Niaki2, Elahe Keyhani3, Iman Bagherizadeh4, Sajjad Biglari3, Farkhondeh Behjati5.
Abstract
Bisphenol-A (BPA) is an industrial xenoestrogen used widely in our living environment. Recently, several studies suggested that BPA has destructive effects on DNA and chromosomes in normal body cells via estrogen receptors (ER). Therefore, BPA could be considered as an important mediator in many diseases such as cancer. However, there are still many controversial issues which need clarification. In this study, we investigated the BPA-induced chromosomal damages in MCF-7 cell line, ER-positive and negative amniocyte cells. Cytotoxicity and genotoxicity effects of BPA were also compared between these three cell groups. Expression of estrogen receptors was determined using immunocytochemistry technique. The cell cytotoxicity of BPA was measured by MTT assay. Classic cytogenetic technique was carried out for the investigation of chromosome damage. BPA, in addition to cytotoxicity, had remarkable genotoxicity at concentrations close to the traceable levels in tissues or biological fluids. Although some differences were observed in the amount of damages between ER-positive and negative fetal cells, interestingly, these differences were not significant. The present study showed that BPA could lead to chromosomal aberrations in both ER-dependent and independent pathways at some concentrations or in cell types yet not reported. Also, BPA could probably be considered as a facilitator for some predisposed cells to be cancerous by raising the chromosome instability levels. Finally, estrogen receptor seems to have a different role in cytotoxicity and genotoxicity effects.Entities:
Keywords: Bisphenol-A (BPA); MCF-7; amniocyte; chromosome abnormality; classic cytogenetics; estrogen receptor
Year: 2016 PMID: 27386435 PMCID: PMC4916780
Source DB: PubMed Journal: Int J Mol Cell Med ISSN: 2251-9637
Fig. 1Immunocytochemistry staining of the estrogen receptors in the cells. MCF-7 as the positive control (A), female amniocytes (B), male amniocytes (C) and MCF-7 cells without the estrogen receptor primary antibodies as the negative control (D
Fig. 2Cytotoxicity evaluation of BPA on MCF-7 cell line using MTT assay, male (A.F-M) and female (A.F-F) amniocytes. The IC50 for MCF-7, male and female amniocytes were about 100, 40 and 4 μg/ml BPA, respectively
Results of chromosomal structural aberrations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 59 | 40 | 0 | 3 | 0 | 0 | 8 | 0 | 45 | 200 | 0 |
|
| 69 | 71 | 55 | 0 | 2 | 0 | 0 | 4 | 0 | 63 | 200 | 0.4 | |
| 88 | 86 | 80 | 0 | 0 | 2 | 0 | 0 | 0 | 86 | 200 | 1 | |
| 234 | 236 | 185 | 9 | 9 | 16 | 0 | 20 | 0 | 180 | 200 | 4 | |
| 208 | 197 | 168 | 3 | 0 | 14 | 0 | 28 | 5 | 158 | 200 | 40 | |
| 72 | 72 | 59 | 0 | 0 | 0 | 0 | 0 | 0 | 72 | 200 | 100 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200 | 0 |
|
| 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 200 | 0.4 | |
| 32 | 32 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 200 | 1 | |
| 50 | 50 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 50 | 200 | 4 | |
| 50 | 50 | 48 | 0 | 0 | 0 | 0 | 0 | 0 | 50 | 200 | 40 | |
| 28 | 28 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 200 | 100 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200 | 0 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200 | 0.4 | |
| 50 | 51 | 48 | 2 | 0 | 0 | 1 | 0 | 0 | 47 | 200 | 1 | |
| 72 | 70 | 69 | 0 | 0 | 0 | 2 | 0 | 0 | 70 | 200 | 4 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 |
Because of high BPA cytotoxicity in this concentration, the analyzed metaphases were less than 200 which were extrapolated to 200;
Because of high BPA cytotoxicity in this concentrations, no analyzable metaphase was observed; Fra: fragments; DM: double minute; M: marker chromosome; Csb: chromosomal breakage; Ctb: chromatid breakage; Csg: chromosomal gap; Ctg: chromatid gap; Tr: triaradial; R: ring chromosome.
Fig. 3Some structural aberrations. A1&2: chromatid gap and chromatid break, respectively in MCF-7; B1&2: fragment and chromosome gap, respectively in MCF-7; C: fragment in female amniocyte
Fig. 4Average amounts of abnormal cells. A: cells with at least one chromosomal structural aberration; B: total structural abnormalities; C,D: two of main structural abnormalities in different concentrations of BPA (μg/ml). AFM: male amniocytes, AFF: female amniocytes, *: p< 0.001, ¥: p< 0.005, £: p< 0.05
Numerical aberrations in cells exposed to different concentrations of BPA
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
|
| Negative (Ctrl) | 8.8 | 13 | 30.3 | 21.7 | 17.4 | 8.8 | - |
| 0.4 | - | 5 | 25 | 25 | 13 | 8.5 | - | |
| 1 | 3.7 | 11.1 | 22.3 | 33.3 | 3.7 | 7.4 | 18.5 | |
| 4 | 15 | 5 | 15 | 15 | 30 | 15 | 5 | |
| 40 | 22.6 | 9 | 13.6 | 18.1 | 13.6 | 9 | 13.5 | |
| 100 | 20 | 9 | 15 | 19 | 13 | 12 | 12 | |
|
| ||||||||
|
|
|
|
|
|
|
| ||
|
| Negative ( Ctrl ) | - | - | - | 100 | - | - | - |
| 0.4 | - | - | - | 100 | - | - | - | |
| 1 | - | - | 3 | 97 | - | - | - | |
| 4 | - | - | - | 96 | 4 | - | - | |
| 40 | - | - | - | 93 | 7 | - | - | |
| 100 | - | - | 12 | 88 | - | - | - | |
| Negative ( Ctrl ) | - | - | - | 100 | - | - | - | |
|
| 0.4 | - | - | - | 100 | - | - | - |
| 1 | - | - | 8 | 88 | 4 | - | - | |
| 4 | - | - | 8 | 53 | 28 | 8 | - | |
| 40 | - | - | - | - | - | - | - | |
| 100 | - | - | - | - | - | - | - | |
: Because of high BPA cytotoxicity in this concentration, the analyzed metaphases were less than 200 which were extended to 200 and percentages were calculated from 200 cells;
Because of high BPA cytotoxicity in this concentrations, no analyzable metaphase was observed;
: p< 0.05
Fig. 5Chromosomal numerical variations in BPA exposed MCF-7 cell line. The color spectrum magnitudes indicate the relative frequency of metaphases in each chromosomal numerical group (each column